← All stocks

Vivos Therapeutics, Inc.

VVOS Net buying
CIK 0001716166 #5497 in the set updated 17 Sep 2026
Bought (120 mo)
$1.95M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.95M
+$1.95M against sales at will

By person

4 insiders · 17 transactions
11.7×

R. Kirk Huntsman holds 11.7 times base salary in stock. $4.79M of shares against $408.70K in salary for 2024.

Salary from the company's own proxy. The shares are what R. Kirk Huntsman last reported holding, valued at $1.34, the price Common Stock was last bought or sold at on the open market here, on 31 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Skaff Michael C
10% owner
$1.81M (2)
+$1.81M
1,353,625
$1.81M
Huntsman Ronald Kirk
Chief Executive Officer
$123.53K (13)
+$123.53K
3,575,521
$4.79M
+2.5%
Amman Bradford K.
Principal Accounting Officer
$12.67K (2)
+$12.67K
250,080
$335.11K
Singh Gurdev Dave
Chief Medical Officer
3,219,705
$4.31M
0.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 4,835,300 to 13,894,600 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 250,000
History held since 14 Dec 2020